Neuropsicofarmacología
![Foto de Neuropsicofarmacología](/img/uploaded/133B5DEFC4D194B6A12E03E329850F74.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (411)
2024
-
Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues
Antioxidants, Vol. 13, Núm. 5
-
Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets
Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106
-
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus
Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373
-
Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects
Translational Psychiatry, Vol. 14, Núm. 1
-
Effects of cannabidiol in post-stroke mood disorders in neonatal rats
Pediatric Research
-
Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands
Bioorganic Chemistry, Vol. 142
-
G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits
Nature communications, Vol. 15, Núm. 1, pp. 4307
-
High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls
Psychiatry Research, Vol. 337
-
Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain
British Journal of Pharmacology
-
Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort
Arthritis Care and Research
-
NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia
Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome
Biomedicines, Vol. 12, Núm. 1
-
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Seminars in Arthritis and Rheumatism, Vol. 66
-
Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia
Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44
-
Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm
International Journal of Rheumatic Diseases, Vol. 27, Núm. 4
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783
2023
-
35S]GTPγS (Guanosine-5'-O-(γ-thio)triphosphate-[35S]) Binding Scintillation Proximity Assay Experiments in Postmortem Brain Tissue
Methods in molecular biology (Clifton, N.J.), Vol. 2687, pp. 31-43
-
ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 928-935
-
Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay
Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275